Publications
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999-1995 | 1994-1985
Establishing the role of the gut microbiota in susceptibility to recurrent urinary tract infections.
J Clin Invest. 2022 Mar 1;132(5):e158497. doi: 10.1172/JCI158497..
StrainGE: a toolkit to track and characterize low-abundance strains in complex microbial communities.
Genome Biol. 2022 Mar 7;23(1):74. doi: 10.1186/s13059-022-02630-0..
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.
Nat Microbiol. 2022 May;7(5):630-639. doi: 10.1038/s41564-022-01107-x. Epub 2022 May 2..
Characterization of Host-Pathogen-Device Interactions in Pseudomonas aeruginosa Infection of Breast Implants.
Plast Reconstr Surg. 2022 Aug 1;150(2):260e-271e. doi: 10.1097/PRS.0000000000009315. Epub 2022 Jun 3..
A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis.
PLoS Pathog. 2021 Jan 29;17(1): doi: 10.1371/journal.ppat.1009314..
Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infections
BMC Microbiol. 2021 Feb 18;21(1):53..
Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.
Nat Rev Microbiol. 2020 Feb 18. DOI: 10.1038/s41579-020-0324-0.
High resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administration.
World J Urol. 2020 Sep; PMCID: PMC7778452 (available on 2021-09-01).
Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat.
mBio. 2020 Sep 29;11(5):e02318-20..
Mucosal infection rewires TNFa signaling dynamics to skew susceptibility to recurrence.
Elife. 2019 Aug 20;8. Pii: e46677. doi: 10.7554/eLife.46677.
(p)ppGpp and CodY promote Enterococcus faecalis Virulence in a Murine Model of Catheter-associated urinary tract infection.
mSphere. 2019 Jul 24;4(4).
Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Sci Rep. 2019 Jul 17;9(1):10393.
Establishment and Characterization of Bacterial Infection of Breast Implants in a Murine Model.
Aesthet Surg J. 2019 Jul 1. Pii: sjz190.
Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumanni chromosomal genes.
Nat Commun. 2019 June 24;10(1):2763.
Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae.
PLoS Pathog. 2019 Jun 10;15(6):e1007671.
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis.
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10510-10517.
Reaching the End of the Line: Urinary Tract Infections.
Microbiol Spectr. 2019 May;7(3).
Deposition of host matrix proteins on breast implant surfaces facilitates Staphylococcus epidermidis biofilm formation: In vitro analysis.
Aesthet Surg J. 2019 April 6.
The widely used antimicrobial triclosan induces high levels of antibiotic tolerance in vitro and reduces antibiotic efficacy up to 100-fold in vivo.
Antimicrob Agents Chemother. 2019 Feb 19.
The detection of bacteria and matrix proteins on clinically benign and pathologic implants.
Plast Reconstr Surg Glob Open. 2019 Feb 8;7(2).
Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner.
PLoS Pathog. 2018 Dec.13;14(12).
Biphenyl Gal and GalNAc FimIH Lectin Antagonists of Uropathogenic E. coli (UPED): Optimization through iterative rational drug design.
J. Med. Chem. 2018. Dec 12; 62(2): 467-479.
Structural basis for usher activation and intramolecular subunit transfer in P pilus biogenesis in E. coli.
Nat Microbiol. 2018 Dec;3(12):1362-1368.
Maganese acquisition is essential for virulence of Enterococcus faecalis.
PLoS Pathog. 2018 Sep 20:14(9): e1007102.
Structure-function analysis of the curli accessory protein CsgE defines surfaces essential for coordinating amyloid fiber formation.
MBio. 2018 Jul 17;9(4).
Differential Regulation of Escherichia coli fim Genes following binding to mannose receptors.
J Pathog. 2018 May 22;20182897581.
Hydrogen sulfide sensing through reactive sulfur species (RSS) and nitroxyl (HNO) in Enterococcus faecalis.
ACS Chem Biol. 2018 May 17.
Precision antimicrobial therapeutics: the path of least resistance?
NPJ Biofilms Microbiomes. 2018 Feb 27;4:4.
Structure-based discovery of glycomimetic FmIH ligands as inhibitors of bacterial adhesion during urinary tract infection.
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2819-E2828.
Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions.
Elife. 2018 Jan 18;7. pii:e31662. Doi: 10.7554/eLife.31662.
Narrowing the spectrum: the new frontier of precision antimicrobials.
Genome Med. 2017 Dec 14;9(1):110.
Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection.
NPJ Biofilms Microbiomes. 2017 Nov 6;3:28.
Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract.
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41);E8721-E8730.
Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist
Nature. 2107 June 14. Doi: 10.1038/nature22972. [Epub ahead of print].
Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions
PLoS Negl Trop Dis. 2017 May 22;11(5).
Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections
Sci Trans Med. 2017 Mar 22;9(382).
Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions
Sci Adv. 2017 Feb 10:3(2), e1601944.
One size doesn’t fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.
Ann Transl Med. 2017 Jan; 5(2):28.
A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.
Nat Microbiol. 2016 Oct 31;2:16196.
Antibody-based therapy for Enterococcal catheter-associated urinary tract infections.
MBio. 2016 Oct 25;7(5).
CRP-cAMP regulates csgD and biofilm formation by uropathogenic Escherichia coli.
J Bacteriol. 2016 Oct 3.
Anti-virulence C-mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections.
J Med Chem. 2016 Sep 30.
Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.
Cell Host Microbe. 2016 Sept 20.
The Ubil (VisC) Aerobic Ubiquinone Synthase is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.
J Bacteriol. 2016 Sep 9;198(19):2662-72.
Solution NMR structure of CsgE: Structural insights into a chaperone and regulator protein important for functional amyloid formation.
Proc Natl Acad Sci U S A. 2016 June 28;113(26):7130-5.
Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis.
MBio. 2016 Apr 12;7(2).
Innovative Solutions to Sticky Situations: Antiadhesive Strategies for Treating Bacterial Infections.
Microbiol Spectr. 2016 Apr;4(2).
Adhesive Pili in TI Pathogenesis and Drug Development.
Pathogens. 2016 March 5(1):30.
Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinty and Efficacy in the Treatment of Chronic UTI.
ChemMedChem. 2016 Feb. 11 (4):367-73.
Drug and Vaccine Development for the treatment and prevention of urinary tract infections.
Microbiol Spectr. 2016 Feb;4(1).
Fibrinogen release and deposition on urinary catheters placed during urologic procedures.
J Urol. 2016 Jan 28.
Structure of a Chaperone-Usher Pilus Reveals the Molecular Basis of Rod Uncoiling.
Cell. 2015 Dec 22.
Bacterial amyloid formation: Structural insights into Curli Biogenesis.
Trends in Microbiol. 2015 Nov;23(11):693-706.
Fueling the fire with fibers: Bacterial amyloids promote inflammatory.
Cell Host Microbe. 2015 Jul 8;18(1):1-2.
The pilus usher controls protein interactions via domain masking and is functional as an oligomer
Nat Struct Mol Biol.. 2015 Jul;22(7);540-6..
Human urine decreases function and expression of Type 1 Pili in uropathogenic Escherichia coli.
MBio. 2015 June 30;6(4)e00820.
Advanced Glycation End Products Facilitate Bacterial Adherence in Urinary Tract Infection in Diabetic Mice.
Pathog Dis. 2015 Jul; 73(5).
The unexplored relationship between urinary tract infections and the autonomic nervous system.
Auton Neurosci.. 2015 June 6.
Urinary tract infections: epidemiology, mechanisms of infection and treatment options.
Nat Rev Microbiol. 2015 May:13(5):269-84.
Role of Hypoxia Inducible Factor-1A (HIF-1a) in innate defense against uropathogenic Escherichia coli infection.
PLoS Pathog. 2015 Apr 30:11(4).
Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.
Pathog Dis. 2015 Apr; 73(3).
Subinhibitory antibiotic therapy alters recrurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.
mBio. 2015 Mar 31;6(2).
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.
Curr Opin Infect Dis. 2015 Feb;28(1):97-105..
Chaos controlled: discovery of a powerful amyloid inhibitor.
Mol Cell. 2015 Feb 5;57(3):391-3.
Dysregulation of Escherichia coli a-hemolysin expression alters the course of acute and persistent urinary tract infection.
Proc Natl Acad Sci U S A. 2015 Feb 9.
Uropathogenic Escherichia coli Superinfection Enhances the Severity of Mouse Bladder Infection.
PLoS Pathog. 2015 Jan 8;11(1):e1004599.
A 2-Pyridone-Amide Inhibitor Targets the Glucose Metabolism Pathway of Chlamydia trachomatis.
mBio. 2014 Dec 30;6(1).
Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis.
EBioMedicine. 2014 Nov 3:1(1)46-57.
Pilicide ec240 Disrupts Virulence Circuuits in Uropathogenic E. coli.
mBIO. 2014 Oct 28;5(6):e02038.
Syntheses and biological evaluation of 2-amino-3-acyltetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activity.
Org Biomol Chem. 2014 Mar 28;12(12):1942-56..
Structural and mechanistic insights into the bacterial amyloid secretion channel CsgG.
Nature. 2014 Sep 14. doi: 10.10nature13768. (Epub ahead of print).
EbpA vaccine antibodies block binding Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice.
Sci Trans Med. 2014 Sep 17. 6:254ra127. DOI:10.1126/scitranslmed.3009384.
Significance of the D-serine-deaminase and D-serine metabolism of Staphylococcus saprophyticus for virulence.
Infect Immun. 2013 Nov.
From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.
Curr Urol Rep. 2013 Oct;14(5):448-56.
Pilin and Sortase Residues Critical for Endocarditis- and Biofilm-Associated Pilus Biogenesis in Enterococcus faecalis.
J Bacteriol. 2013 Oct;195(19):4484-95.
Strong cross-system interactions drive the activation of the QseB response regulator in the absence of its cognate sensor.
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16592-7.
A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic escherichia coli ST131.
J Infect Dis. 2013 Sep;208(6):921-8.
Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation.
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15530-7.
Escherichia coli biofilms have an organized and complex extracellular matrix structure.
MBio. 2013 Sep 10;4(5):e00645-13.
Estrogen and recurrent UTI: what are the facts?
Sci Transl Med. 2013 Jun 19;5(190):190.
Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes.
Infect Immun. 2013 May;81(5):1606-17..
AhrC and Eep are biofilm infection-associated virulence factors in Enterococcus faecalis.
Infect Immun. 2013 May;81(5):1696-708.
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.
Sci Transl Med. 2013 May 8;5(184):184.
Structural and energetic basis of folded-protein transport by the FimD usher.
Nature. 2013 Apr 11;496(7444):243-6.
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.
Cold Spring Harb Perspect Med. 2013 Apr 1;3(4).
Dissection of pilus tip assembly by the FimD usher monomer.
J Mol Biol. 2013 Mar 11;425(5):958-67.
The complex interactions of bacterial pathogens and host defenses.
Curr Opin Microbiol. 2013 Feb;16(1):1-3.
Enterococcus faecalis Overcomes Foreign Body-Mediated Inflammation To Establish Urinary Tract Infections.
Infect Immun. 2013 Jan;81(1):329-39.
Immune Modulation by Group B Streptococcus Influences Host Susceptibility to Urinary Tract Infection by Uropathogenic Escherichia coli.
Infect Immun. 2012 Dec;80(12):4186-94.
Structure of the PapD-PapGII pilin complex reveals an open and flexible P5 pocket.
J Bacteriol. 2012 Dec;194(23):6390-7.
Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors
J Bacteriol. 2012 Nov;194(22):6195-205.
Escherichia coli-mediated impairment of ureteric contractility is UPEC-specific.
J Infect Dis. 2012 Nov 15;206(10):1589-96.
Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics.
Virulence. 2012 Nov 15;3(7).
Combination small molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45.
Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.
Infect Immun. 2012 Aug;80(8):2826-34.
The Metal Ion-Dependent Adhesion Site Motif of the Enterococcus faecalis EbpA Pilin Mediates Pilus Function in Catheter-Associated Urinary Tract Infection.
MBio. 2012 Jul 24;3(4).
Domain activities of PapC usher reveal the mechanism of action of an Escherichia coli molecular machine.
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9563-8.
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
FEMS Microbiol Rev. 2012 May;36(3):616-48.
Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure-activity study.
Bioorg Med Chem. 2012 May 1;20(9):3128-42.
What does it take to stick around?: Molecular insights into biofilm formation by uropathogenic Escherichia coli.
Virulence. 2012 May 1;3(3) 231-3.
Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl Mannosides.
J Med Chem. 2012 Apr 26;55(8):3945-59.
The E. coli CsgB nucleator of curli assembles to β-sheet oligomers that alter the CsgA fibrillization mechanism.
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6502-7.
Design and synthesis of fluorescent pilicides and curlicides: bioactive tools to study bacterial virulence mechanisms.
Chemistry. 2012 Apr 10;18(15):4522-32.
Impairment of the biomechanical compliance of P pili: a novel means of inhibiting uropathogenic bacterial infections?
Eur Biophys J. 2012 Mar;41(3):285-95.
Synthetic polymer nanoparticles conjugated with FimH(A) from E. coli pili to emulate the bacterial mode of epithelial internalization.
J Am Chem Soc. 2012 Mar 7;134(9):3938-41.
Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.
J Am Chem Soc. 2012 Feb 22;134(7):3439-44.
Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors.
Science Transl Med. 2011 Nov 16;3(109).
Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.
Infect Immun. 2011 Oct;79(10):4250-9.
Immune Activation and Suppression by Group B Streptococcus in a Murine Model of Urinary Tract Infection.
Infect Immun. 2011 Sep;79(9):3588-95.
CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation.
Mol Microbiol. 2011 Jul;81(2):486-99.
Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate.
Nature. 2011 Jun 2;474(7349):49-53.
A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.
Mol Microbiol. 2011 Jun;80(6):1516-29.
Antitoxins: therapy for stressed bacteria.
Nat Chem Biol. 2011 Jun;7(6):345-7.
Update on biofilm infections in the urinary tract.
World J Urol. 2011 May 18.
Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli.
Microbes Infect. 2011 May;13(5):426-37.
Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity.
Eur J Med Chem. 2011 Apr;46(4):1103-16.
Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin.
Structure. 2011 Feb 9;19(2):192-202.
Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: pilicides with increased antivirulence activity.
J Med Chem. 2010 Aug 12;53(15):5690-5.
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.
PLoS Pathog. 2010 Aug 12;6(8).
Enterococcal Biofilm Formation and Virulence in an Optimized Murine Model of Foreign Body-Associated Urinary Tract Infections.
Infect Immun. 2010 Aug 9.
Structure-based drug design and optimization of mannoside bacterial FimH antagonists.
J Med Chem. 2010 Jun 24;53(12):4779-92.
A tale of two pili: assembly and function of pili in bacteria.
Trends Microbiol. 2010 May;18(5):224-32.
Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.
Infect Immun. 2010 Mar;78(3):963-75.
The differential affinity of the usher for chaperone-subunit complexes is required for assembly of complete pili.
Mol Microbiol. 2010 Feb 24.
Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence.
Infect Immun. 2010 Feb 22.
Virulence Plasmid Harbored by Uropathogenic E. coli Functions in Acute Stages of Pathogenesis.
Infect Immun. 2010 Feb 1.
Structural homology between the C-terminal domain of the PapC usher and its plug.
J Bacteriol. 2010 Jan 29.
Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22439-44.
Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.
Nat Chem Biol. 2009 Dec;5(12):913-9.
Structural biology of the chaperone-usher pathway of pilus biogenesis.
Nature Rev Microbiol. 2009 Nov;7(11):765-74.
Bacterial adhesion – A source of alternate antibiotic targets.
IDrugs. 2009 Nov;12(11):699-705.
Contribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm development.
Infect Immun. 2009 Sep;77(9):3626-38.
A murine model of urinary tract infection.
Nature Protoc. 2009;4(8):1230-43.
QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli.
Mol Microbiol. 2009 Sep;73(6):1020-31.
Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.
J Infect Dis. 2009 Aug 15;200(4):528-36.
Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection.
Cell Host Microbe. 2009 May 8;5(5):463-75.
Mechanism for sortase localization and role in efficient pilus assembly in Enterococcus faecalis.
J Bacteriol. 2009 Mar 13.
The vital role of ORWH.
Science. 2009 Feb 20;323(5917):1009-10.
Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.
PLoS Pathog. 2009 Feb;5(2):e1000305.
Localized and efficient curli nucleation requires the chaperone-like amyloid assembly protein CsgF.
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):900-5. Epub 2009 Jan 8.
G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.
Cell Microbiol. 2008 Dec;10(12):2568-78.
Structural determinants of polymerization reactivity of the P pilus adaptor subunit PapF.
Structure. 2008 Nov 12;16(11):1724-31.
Streptozocin-induced diabetic mouse model of urinary tract infection.
Infect Immun. 2008 Sep;76(9):4290-8.
Fiber formation across the bacterial outer membrane by the chaperone/usher pathway.
Cell. 2008 May 16;133(4):640-52.
Molecular Variations in Klebsiella pneumoniae and Escherichia coli FimH Affect Function and Pathogenesis in the Urinary Tract.
Infect Immun. 2008 May 12.
Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli.
Bioorg Med Chem Lett. 2008 May 7.
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.
PLoS ONE. 2008 Apr 30;3(4):e2040.
Utilization of an IBC Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression.
Infect Immun. 2008 Apr 14.
Infectious disease and women’s health.
Nat Rev Microbiol. 2008 Apr;6(4):254.
Morphological plasticity as a bacterial survival strategy.
Nat Rev Microbiol. Feb 2008.
LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis.
Mol Microbiol. 2008 Jan 7;67(1):116-128.
The biology and future prospects of antivirulence therapies.
Nat Rev Microbiol. 2008 Jan;6(1):17-27.
Detection of intracellular bacterial communities in human urinary tract infection.
PLoS Med. 2007 Dec 18;4(12):e329.
Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili.
Cell Microbiol. 2007 Sep;9(9):2230-41.
Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled.
J Biol Chem. 2007 Jul 20;282(29):21259-67.
Adaptor function of PapF depends on donor strand exchange in P-pilus biogenesis of Escherichia coli.
J Bacteriol. 2007 Jul;189(14):5276-83.
Crystal structure of the P pilus rod subunit PapA.
PLoS Pathog. 2007 May 18;3(5):e73.
Recognition of the N-terminal lectin domain of FimH adhesin by the usher FimD is required for type 1 pilus biogenesis.
Mol Microbiol. 2007 Apr;64(2):333-46.
Pilicides regulate pili expression in E. coli without affecting the functional properties of the pilus rod.
Mol Biosyst. 2007 Mar;3(3):214-8.
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
Infect Immun. 2007 Jan;75(1):52-60.
Filamentation by Escherichia coli subverts innate defenses during urinary tract infection.
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19884-9.
Molecular mechanism of P pilus termination in uropathogenic Escherichia coli.
EMBO Rep. 2006 Dec;7(12):1228-32.
Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria.
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17897-902.
The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques.
Biophys J. 2006 Nov 15;91(10):3848-56.
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14170-5.
Design, synthesis and evaluation of peptidomimetics based on substituted bicyclic 2-pyridones-Targeting virulence of uropathogenic E. coli.
Bioorg Med Chem. 2006 Aug 10.
Maturation of intracellular Escherichia coli communities requires SurA.
Infect Immun. 2006 Aug;74(8):4793-800.
Donor-strand exchange in chaperone-assisted pilus assembly proceeds through a concerted beta strand displacement mechanism.
Mol Cell. 2006 Jun 23;22(6):831-42.
Sticky Fibers and Uropathogenesis: Bacterial Adhesins in the Urinary Tract.
Future Microbiol. 2006 Jun;1:75-87. Review.
Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5977-82.
LRP6 Holds the Key for the Entry of Anthrax Toxin.
Cell. (2006) 124, 3-5.
Secretion of curli fibre subunits is mediated by the outer membrane-localized CsgG protein.
Mol. Microbiol. 2006 Feb;59(3):870-881.
Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization
Infection and Immunity. 2005, in press.
Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli.
J Bacteriol. 2005 Nov;187(22):7680-6.
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.
Infection and Immunity. 2005; 73(11):7657-7668.
Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.
Infect Immun. 2005 Jul;73(7):3999-4006.
Blueprinting the regulatory response of Escherichia coli to the urinary tract.
Trends Microbiol. 2005 Jun;13(6):246-8.
Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice.
Infect Immun. 2005 Apr;73(4):2461-8.
Structure-activity relationships of galabioside derivatives as inhibitors of E. coli and S. suis adhesins: nanomolar inhibitors of S. suis adhesins.
Org Biomol Chem. 2005 Mar 7;3(5):886-900. Epub 2005 Feb 04.
Multivariate Design, Synthesis, and Biological Evaluation of Peptide Inhibitors of FimC/FimH Protein-Protein Interactions in Uropathogenic Escherichia coli.
J Med Chem. 2005 Feb 24;48(4):935-945.
Down-regulation of the kps region 1 capsular assembly operon following attachment of Escherichia coli type 1 fimbriae to D-mannose receptors.
Infect Immun. 2005 Feb;73(2):1226-31.
Interaction of uropathogenic Escherichia coli with host uroepithelium.
Curr Opin Microbiol. 2005 Feb;8(1):54-9.
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
Mol Microbiol. 2005 Jan;55(2):441-55.
Catalysis of protein folding by chaperones in pathogenic bacteria.
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17389-93. Epub 2004 Dec 06..
Fiber assembly by the chaperone-usher pathway.
Biochim Biophys Acta. 2004 Nov 11;1694(1-3):259-67. Review.
Host subversion by formation of intracellular bacterial communities in the urinary tract.
Microbes Infect. 2004 Oct;6(12):1094-101. Review.
Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
Trends Microbiol. 2004 Sep;12(9):424-30.
Structural biology: anthrax hijacks host receptor.
Nature. 2004 Aug 19;430(7002):843-4. No abstract available.
P pilus assembly motif necessary for activation of the CpxRA pathway by PapE in Escherichia coli.
J Bacteriol. 2004 Jul;186(13):4326-37.
Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
J Urol. 2004 Apr;171(4):1682-5.
Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication.
Kidney Int. 2004 Mar;65(3):791-7.
The Legionella pneumophila PilT homologue DotB exhibits ATPase activity that is critical for intracellular growth.
J Bacteriol. 2004 Mar;186(6):1658-66.
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.
Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5): 1333-8. Epub 2004 Jan 22.
Targeting virulence for antimicrobial chemotherapy.
Curr Opin Pharmacol. 2003 Oct;3(5):513-9.
Intracellular bacterial biofilm-like pods in urinary tract infections.
Science. 2003 Jul 4;301(5629):105-7.
Escherichia coli’s How-To Guide for Forming Amyloid.
ASM News. 2003. 69:3 pp. 121-126.
Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides.
Bioorg Med Chem. 2003 May 15;11(10):2255-2261.
Chaperone-subunit-usher interactions required for donor strand exchange during bacterial pilus assembly.
J Bacteriol. 2003 May;185(9):2723-30.
Stereoselective synthesis of optically active bicyclic beta-lactam carboxylic acids that target pilus biogenesis in pathogenic bacteria.
Org Biomol Chem. 2003 Apr 21;1(8):1308-14.
Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4203-8. Epub 2003 Mar 24.
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.
Infect Immun. 2003 Mar;71(3):1470-80.
Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.
Infect Immun. 2002 Dec;70(12):7042-9.
Design and parallel solid-phase synthesis of ring-fused 2-pyridinones that target pilus biogenesis in pathogenic bacteria.
J Comb Chem. 2002 Nov-Dec;4(6):630-9.
Chaperone priming of pilus subunits facilitates a topological transition that drives fiber formation.
Cell. 2002 Nov 15;111(4):543-51.
Bacterial outer membrane ushers contain distinct targeting and assembly domains for pilus biogenesis.
J Bacteriol. 2002 Nov;184(22):6260-9.
Escherichia coli DegP protease cleaves between paired hydrophobic residues in a natural substrate: the PapA pilin.
J Bacteriol. 2002 Oct;184(20):5762-71.
Recent advances in the molecular basis of pathogen recognition and host responses in the urinary tract.
Int Rev Immunol. 2002 Jul-Oct;21(4-5):291-304.
Structure of the S pilus periplasmic chaperone SfaE at 2.2 A resolution.
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 Pt 2):1016-22.
Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli.
Int J Antimicrob Agents. 2002 Jun;19(6):457-60.
Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.
Mol Microbiol. 2002 May;44(4):903-15.
Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.
J Biol Chem. 2002 Mar 1;277(9):7412-9. Epub 2001 Dec 13.
Role of Escherichia coli curli operons in directing amyloid fiber formation.
Science. 2002 Feb 1;295(5556):851-5.
Real-time and equilibrium (19)F-NMR studies reveal the role of domain-domain interactions in the folding of the chaperone PapD.
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):709-14. Epub 2002 Jan 15.
Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli.
Cell Microbiol. 2002 Jan;4(1):19-28.
Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli.
Chembiochem. 2001 Dec 3;2(12):915-8.
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
Infect Immun. 2001 Jul;69(7):4572-9.
Dynamic interactions between host and pathogen during acute urinary tract infections.
Urology. 2001 Jun;57(6 Suppl 1):56-61.
Uropathogenic escherichia coli: interactions with bladder epithelium.
Urology. 2001 Jun;57(6 Suppl 1):105-6.
Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili.
EMBO J. 2001 Apr 2;20(7):1508-1.
Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
J Infect Dis. 2001 Mar 1;183 Suppl 1:S36-40.
Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
J Immunol. 2001 Jan 15;166(2):1148-55.
Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor.
Cell. 2001 Jun 15;105(6):733-43.
Chaperone-assisted pilus assembly and bacterial attachment.
Curr Opin Struct Biol. 2000 Oct;10(5):548-56.
Role of intestinal surfactant-like particles as a potential reservoir of uropathogenic Escherichia coli.
Biochim Biophys Acta. 2000 Sep 1;1523(1):49-55.
Multiple pathways allow protein secretion across the bacterial outer membrane.
Curr Opin Cell Biol. 2000 Aug;12(4):420-30.
Snapshots of usher-mediated protein secretion and ordered pilus assembly.
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9240-5.
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35.
Stereoselective synthesis of optically active beta-lactams, potential inhibitors of pilus assembly in pathogenic bacteria.
Org Lett. 2000 Jul 13;2(14):2065-7.
PapD-like chaperones provide the missing information for folding of pilin proteins.
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7709-14.
Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story.
Microbes Infect. 2000 Jul;2(9):1061-72.
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
EMBO J. 2000 Jun 15;19(12):2803-12.
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.
J Cell Biol. 2000 Mar 20;148(6):1305-15.
Evidence for donor strand complementation in the biogenesis of Haemophilus influenzae haemagglutinating pili.
Mol Microbiol. 2000 Mar;35(6):1335-47.
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
J Infect Dis. 2000 Feb;181(2):774-8.
Bacterial pili: molecular mechanisms of pathogenesis.
Curr Opin Microbiol. 2000 Feb;3(1):65-72.
PapD-like chaperones and pilus biogenesis.
Semin Cell Dev Biol. 2000 Feb;11(1):27-34.
Assembly of complex organelles: pilus biogenesis in gram-negative bacteria as a model system.
Methods. 2000 Jan;20(1):111-26.
Binding of pili from uropathogenic Escherichia coli to membranes secreted by human colonocytes and enterocytes.
Infect Immun. 1999 Nov;67(11):6161-3. PMID: 10531281.
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.
Science. 1999 Oct 1;286(5437):113-7. PMID: 10506557.
Structural basis of chaperone function and pilus biogenesis.
Science. 1999 Aug 13;285(5430):1058-61. PMID: 10446050.
X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli.
Science. 1999 Aug 13;285(5430):1061-6. PMID: 10446051.
Structural basis of chaperone self-capping in P pilus biogenesis.
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8178-83. PMID: 10393968.
Bacterial adhesins: common themes and variations in architecture and assembly.
J Bacteriol. 1999 Feb;181(4):1059-71. Review. No abstract available. PMID: 9973330.
Probing conserved surfaces on PapD.
Mol Microbiol. 1999 Feb; 31(3):773-83. PMID: 10048022.
Pilus biogenesis via the chaperone/usher pathway: an integration of structure and function.
J Struct Biol. 1998 Dec 15;124(2-3):201-20. Review. PMID: 10049807.
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
Science. 1998 Nov 20;282(5393):1494-7. Erratum in: Science 1999 Feb 5;283(5403):795. PMID: 9822381.
Binding of peptides in solution by the Escherichia coli chaperone PapD as revealed using an inhibition ELISA and NMR spectroscopy.
Bioorg Med Chem. 1998 Nov;6(11):2085-101. PMID: 9881099.
Periplasmic chaperone recognition motif of subunits mediates quaternary interactions in the pilus.
EMBO J. 1998 Nov 2;17(21):6155-67. PMID: 9799225.
Ramifications of kinetic partitioning on usher-mediated pilus biogenesis.
EMBO J. 1998 Apr 15;17(8):2177-85. PMID: 9545231.
The chaperone/usher pathway: a major terminal branch of the general secretory pathway.
Curr Opin Microbiol. 1998 Apr;1(2):223-31. Review. PMID: 10066482.
The PapC usher forms an oligomeric channel: implications for pilus biogenesis across the outer membrane.
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3146-51. PMID: 9501230.
Efficient Regioselective Synthesis of Enantiomerically Pure 4-Hydroxymethyl-D2 Thiazoline.
Tetrahedron Lett. 1998; 39: 2293-2294.
The chaperone-assisted membrane release and folding pathway is sensed by two signal transduction systems.
EMBO J. 1997 Nov 3;16(21):6394-406. PMID: 9351822.
Transferred nuclear Overhauser effect spectroscopy study of a peptide from the PapG pilus subunit bound by the Escherichia coli PapD chaperone.
FEBS Lett. 1997 Jul 21;412(1):115-20. PMID: 9257702.
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Science. 1997 Apr 25;276(5312):607-11. PMID: 9110982.
Development of pilus organelle subassemblies in vitro depends on chaperone uncapping of a beta zipper.
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12890-5. PMID: 8917515.
PapG adhesin from E. coli J96 recognizes the same saccharide epitope when present on whole bacteria and as isolated protein.
Bioorg Med Chem. 1996 Nov;4(11):1809-17. PMID: 9007266.
Haemophilus influenzae pili are composite structures assembled via the HifB chaperone.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11913-8. PMID: 8876237.
Molecular basis of two subfamilies of immunoglobulin-like chaperones.
EMBO J. 1996 Aug 1;15(15):3792-805. PMID: 8670884.
Molecular dissection of PapD interaction with PapG reveals two chaperone-binding sites.
Mol Microbiol. 1995 Jun;16(5):1011-20. PMID: 7476177.
Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli.
Mol Microbiol. 1995 Jun;16(5):1021-9. PMID: 7476178.
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae.
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5. PMID: 7892228.
Specificity mapping of bacterial lectins by inhibition of hemagglutination using deoxy and deoxyfluoro analogs of receptor-active saccharides.
Methods Enzymol. 1995;253:105-14. No abstract available. PMID: 7476379.
Peptides inhibit complexation of the bacterial chaperone PapD and reveal potential to block assembly of virulence associated pili.
Bioorganic and Medical Chemical Letters. 1995; 5, 927-932.
A novel secretion apparatus for the assembly of adhesive bacterial pili.
Trends Microbiol. 1993 May;1(2):50-5. Review. PMID: 7913856.
Adhesin presentation in bacteria requires molecular chaperones and ushers.
Infect Immun. 1992 Nov;60(11):4445-51. Review. No abstract available. PMID: 1356928.
Biogenesis of pili adhesins associated with urinary tract infectious Escherichia coli.
Antonie Van Leeuwenhoek. 1988; 54(5): 405-9. No abstract available. PMID: 2904797.
Biogenesis of the bacterial pilus.
Curr Opin Genet Dev. 1991 Oct;1(3):313-8. Review. PMID: 1688123.
Chaperone-assisted assembly and molecular architecture of adhesive pili.
Annu Rev Microbiol. 1991;45:383-415. Review. PMID: 1683764.
Chaperone-assisted self-assembly of pili independent of cellular energy.
J Biol Chem. 1994 Apr 29;269(17):12447-55. PMID: 7909802.
Conserved immunoglobulin-like features in a family of periplasmic pilus chaperones in bacteria.
EMBO J. 1992 Apr;11(4):1617-22. PMID: 1348692.
FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8397-401. PMID: 8104335.
Genetic, biochemical, and structural studies of biogenesis of adhesive pili in bacteria.
Methods Enzymol. 1994;236:282-306. No abstract available. PMID: 7968616.
Immunoglobulin-like PapD chaperone caps and uncaps interactive surfaces of nascently translocated pilus subunits.
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10586-90. PMID: 1683704.
Improved transmission electron microscopy technique for the study of cytologic material.
Acta. Cytol. 1985; 29:179-183.
Initiation of assembly and association of the structural elements of a bacterial pilus depend on two specialized tip proteins.
EMBO J. 1993 Mar;12(3):837-47. PMID: 8096174.
Interactive surface in the PapD chaperone cleft is conserved in pilus chaperone superfamily and essential in subunit recognition and assembly.
EMBO J. 1992 Dec;11(13):4747-56. PMID: 1361168.
Mannose-sensitive haemagglutination in the absence of piliation in Escherichia coli.
Mol Microbiol. 1990 Aug;4(8):1311-8. PMID: 1980711.
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli.
J Biol Chem. 1993 Feb 5;268(4):3009-15. PMID: 8094080.
Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes.
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3670-4. PMID: 8097321.
P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips.
Nature. 1992 Mar 19;356(6366):252-5. PMID: 1348107.
PapD and superfamily of periplasmic immunoglobulin-like pilus chaperones.
Adv Protein Chem. 1993;44:99-123. Review. PMID: 8100380.
PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA.
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11552-6. PMID: 797210.
PapD, a periplasmic transport protein in P-pilus biogenesis.
J Bacteriol. 1989 Nov;171(11):6052-8. PMID: 2572580.
Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition.
Cell. 1993 Jun 4;73(5):887-901. Review. No abstract available. PMID: 8098994.
Probing of the combining site of the PapG adhesin of uropathogenic E. coli bacteria by synthetic analogues of galabiose.
J. Amer. Chem. Soc. 1989; 111: 6364-6368.
Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli.
Infect Immun. 1986 Dec; 54: 613-20. PMID: 2877947.
Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.
Infect Immun. 1987 Feb; 55(2): 373-80. PMID: 2879794.
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
Infect Immun. 1985 Nov;50(2):370-7. PMID: 2865209.
Stable fiber-forming and nonfiber-forming chaperone-subunit complexes in pilus biogenesis.
J Biol Chem. 1994 Apr 22;269(16):12233-9. PMID: 7909317.
Structural basis of pilus subunit recognition by the PapD chaperone.
Science. 1993 Nov 19;262(5137):1234-41. PMID: 790191.
The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus.
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4357-61. PMID: 2567514.
The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity.
Infect Immun. 1994 Dec;62(12):5296-304. PMID: 7960108.